Latest Breaking News On - Preliminary biomarker data - Page 1 : comparemela.com

Scholar Rock (SRRK) Presents New Data from Phase 1 DRAGON Trial Showing Promising Anti-Tumor Activity in Anti-PD-1 Resistant Metastatic ccRCC Patients

Scholar Rock (SRRK) Presents New Data from Phase 1 DRAGON Trial Showing Promising Anti-Tumor Activity in Anti-PD-1 Resistant Metastatic ccRCC Patients
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSan diego convention centerSan diegoJay backstromSusan henryTimothy yapTranslational sciencesScholar rock incDepartment of investigational cancer therapeuticsSociety for immunotherapy of cancerUniversity of texas md anderson cancer centerScholar rockAnnual meetingChief executive officerEstablishing proofPreliminary biomarker data

Scholar Rock Presents New Data from Phase 1 DRAGON Trial Showing Promising Anti-Tumor Activity in Anti-PD-1 Resistant Metastatic ccRCC Patients and Supporting SRK-181 Continued Tolerability

Scholar Rock Presents New Data from Phase 1 DRAGON Trial Showing Promising Anti-Tumor Activity in Anti-PD-1 Resistant Metastatic ccRCC Patients and Supporting SRK-181 Continued Tolerability
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

San diego convention centerUnited statesSan diegoUnited kingdomJay backstromRushmie nofsingerTimothy yapSusan henryMolly macleodExchange commissionScholar rock incUniversity of texas md anderson cancer centerSociety for immunotherapy of cancerTranslational sciencesDepartment of investigational cancer therapeuticsAnnual meeting

Scholar Rock to Present Clinical and Biomarker Data from the Phase 1 DRAGON Trial at the SITC 38th Annual Meeting

Poster presentations to include safety, efficacy, and biomarker data from Part A and B of the DRAGON trial in patients with advanced solid tumors treated with SRK-181 .

United statesJay backstromTimothy yapSusan henrySan diego convention centerExchange commissionUniversity of texas md anderson cancer centerTranslational sciencesDepartment of investigational cancer therapeuticsScholar rock incSociety for immunotherapy of cancerScholar rockAnnual meetingSan diegoChief executive officerEstablishing proof